AVE 33.3% 0.2¢ avecho biotechnology limited

ethics approval, page-59

  1. 5,763 Posts.
    lightbulb Created with Sketch. 309

    Yes Jev, POH have a long history now of not giving a toss about getting things done commercially.
    Disgraceful considering what they have had at their disposal. And because of that trust has been broken. Thus how do we beleive "the plan" for latest programs to ever be successfully commercialised? They haven't done it with anything else. Always in "discussion" though. No need for deals when you can just keep doing further cap raisings and promising new products rather than capitalising on already developed products.

    .
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.